Publikationen von Klaus-Armin Nave

Kassmann, C. M.; Quintes, S.; Rietdorf, J.; Möbius, W.; Sereda, M. W.; Nientiedt, T.; Saher, G.; Baes, M.; Nave, K.-A.: A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity. FEBS Letters 585 (14), S. 2205 - 2211 (2011)

Saher, G.; Quintes, S.; Nave, K.-A.: Cholesterol: a novel regulatory role in myelin formation. The Neuroscientist 17 (1), S. 79 - 93 (2011)

Syed, Y. A.; Hand, E.; Möbius, W.; Zhao, C.; Hofer, M.; Nave, K.-A.; Kotter, M. R.: Inhibition of CNS Remyelination by the Presence of Semaphorin 3A. The Journal of Neuroscience 31 (10), S. 3719 - 3728 (2011)

Wüstenberg, T.; Begemann, M.; Bartels, C.; Gefeller, O.; Stawicki, S.; Hinze-Selch, D.; Mohr, A.; Falkai, P.; Aldenhoff, J. B.; Knauth, M. et al.; Nave, K.-A.; Ehrenreich, H.: Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Molecular Psychiatry 16 (1), S. 26 - 36 (2011)

Wüstenberg, T.; Begemann, M.; Bartels, C.; Gefeller, O.; Stawicki, S.; Hinze-Selch, D.; Mohr, A.; Falkai, P.; Aldenhoff, J.; Knauth, M. et al.; Nave, K. A.; Ehrenreich, H.: EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Molecular Psychiatry 16, 1 (2011)

Nave, K.-A.: Myelination and support of axonal integrity by glia. Nature 468 (7321), S. 244 - 252 (2010)

Ribbe, K.; Friedrichs, H.; Begemann, M.; Grube, S.; Papiol, S.; Kästner, A.; Gerchen, M. F.; Ackermann, V.; Tarami, A.; Treitz, A. et al.; Flögel, M.; Adler, L.; Aldenhoff, J. B.; Becker-Emner, M.; Becker, T.; Czernik, A.; Dose, M.; Folkerts, H.; Freese, R.; Guenther, R.; Herpertz, S.; Hesse, D.; Kruse, G.; Kunze, H.; Franz, M.; Lohrer, F.; Maier, W.; Mielke, A.; Müller-Isberner, R.; Oestereich, C.; Pajonk, F.-G.; Pollmächer, T.; Schneider, U.; Schwarz, H.-J.; Kröner-Herwig, B.; Havemann-Reinecke, U.; Frahm, J.; Stühmer, W.; Falkai, P.; Brose, N.; Nave, K.-A.; Ehrenreich, H.: The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 10, 91 (2010)

Karim, S. A.; Barrie, J. A.; McCulloch, M. C.; Montague, P.; Edgar, J. M.; Iden, D. L.; Anderson, T. J.; Nave, K.-A.; Griffiths, I. R.; McLaughlin, M.: PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease. Glia 58 (14), S. 1727 - 1738 (2010)

Bottelbergs, A.; Verheijden, S.; Hulshagen, L.; Gutmann, D. H.; Goebbels, S.; Nave, K.-A.; Kassmann, C. M.; Baes, M.: Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes. Glia 58 (13), S. 1532 - 1543 (2010)

Begemann, M.; Grube, S.; Papiol, S.; Malzahn, D.; Krampe, H.; Ribbe, K.; Friedrichs, H.; Radyushkin, K. A.; El-Kordi, A.; Benseler, F. et al.; Hannke, K.; Sperling, S.; Schwerdtfeger, D.; Thanhäuser, I.; Gerchen, M. F.; Ghorbani, M.; Gutwinski, S.; Hilmes, C.; Leppert, R.; Ronnenberg, A.; Sowislo, J.; Stawicki, S.; Stödtke, M.; Szuszies, C.; Reim, K.; Riggert, J.; Eckstein, F.; Falkai, P.; Bickeböller, H.; Nave, K.-A.; Brose, N.; Ehrenreich, H.: Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Archives of General Psychiatry 67 (9), S. 879 - 888 (2010)

Kolodziejczyk, K.; Saab, A. S.; Nave, K.-A.; Attwell, D.: Why do oligodendrocyte lineage cells express glutamate receptors? F1000 Biology Reports 2, 57 (2010)

Goebbels, S.; Oltrogge, J.; Kemper, R.; Heilmann, I.; Bormuth, I.; Wolfer, S.; Wichert, S. P.; Möbius, W.; Liu, X.; Lappe-Siefke, C. et al.; Rossner, M. J.; Groszer, M.; Suter, U.; Frahm, J.; Boretius, S.; Nave, K.-A.: Elevated Phosphatidylinositol 3,4,5-Trisphosphate in Glia Triggers Cell-Autonomous Membrane Wrapping and Myelination. The Journal of Neuroscience 30 (26), S. 8953 - 8964 (2010)

Gu, C.; Stein, G. C.; Pan, N.; Goebbels, S.; Hörnberg, H.; Nave, K.-A.; Herrera, P.; White, P.; Kaestner, K. H.; Sussel, L. et al.; Lee, J. E.: Pancreatic β Cells Require NeuroD to Achieve and Maintain Functional Maturity. Cell Metabolism 11 (4), S. 298 - 310 (2010)

Nave, K.-A.: Myelination and the trophic support of long axons. Nature Reviews Neuroscience 11 (4), S. 275 - 283 (2010)

Nave, K.-A.: Oligodendrocytes and the “Micro Brake” of Progenitor Cell Proliferation. Neuron 65 (5), S. 577 - 579 (2010)

Quintes, S.; Goebbels, S.; Saher, G.; Schwab, M. H.; Nave, K.-A.: Neuron-glia signaling and the protection of axon function by Schwann cells. Journal of the Peripheral Nervous System 15 (1), S. 10 - 16 (2010)

Kawabe, H.; Neeb, A.; Dimova, K.; Young, S. M.; Takeda, M.; Katsurabayashi, S.; Mitkovski, M.; Malakhova, O. A.; Zhang, D.-E.; Umikawa, M. et al.; Kariya, K.-i.; Goebbels, S.; Nave, K.-A.; Rosenmund, C.; Jahn, O.; Rhee, J. S.; Brose, N.: Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development. Neuron 65 (3), S. 358 - 372 (2010)

Kroner, A.; Ip, C. W.; Thalhammer, J.; Nave, K.-A.; Martini, R.: Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice. American Journal of Pathology 176 (2), S. 549 - 555 (2010)

Bremer, J.; Baumann, F.; Tiberi, C.; Wessig, C.; Fischer, H.; Schwarz, P.; Steele, A. D.; Toyka, K. V.; Nave, K.-A.; Weis, J. et al.; Aguzzi, A.: Axonal prion protein is required for peripheral myelin maintenance. Nature Neuroscience 13 (3), S. 310 - 318 (2010)

Barrie, J. A.; Montague, P.; Karim, S.; Kirkham, D.; Nave, K.-A.; Anderson, T. J.; Griffiths, I. R.; McLaughlin, M.: Modulation of rumpshaker phenotype with wild-type PLP/DM20 suggests several pathogenic mechanisms. Journal of Neuroscience Research 88 (10), S. 2135 - 2145 (2010)